Home  Media Press releases 2002
|
|
|
| 24 May 2002 | 2002-05-24T00:00:00.0000000+01:00 |
| ASTRAZENECA APPOINTS NEW R&D LEADERSHIP TEAM -
R&D Director to Retire
AstraZeneca today announced the appointment of Dr. Martin Nicklasson as Executive Vice President, Development, with responsibility for global drug development and Dr. Jan Lundberg, Executive Vice President, Discovery Research, responsible for all global discovery programmes. Both Dr. Nicklasson and Dr. Lundberg will join the company's Senior Executive Team and report to the Chief Executive, Tom McKillop. The appointments will take effect immediately following the planned retirement of Dr.Claes Wilhelmsson as a Director of AstraZeneca plc on 30th June 2002. | Tom McKillop, Chief Executive, AstraZeneca said: "Claes Wilhelmsson has made a huge contribution to the success of AstraZeneca. His leadership has been critical to the creation of a vibrant R&D organisation that we believe ranks with the best in the industry. Both Martin Nicklasson and Jan Lundberg will bring excellent scientific and leadership skills to AstraZeneca's Senior Executive Team and will continue to build on the solid foundation created by Claes." Biographies |
Emily Denney
+44 (0)20 7304 5034
Steve Brown
+44 (0)20 7304 5033
|
|
Mina Blair-Robinson
+44 (0)20 7304 5084
Jonathan Hunt
+44 (0)20 7304 5087
|
|
|
|